Erich Schlick, M.d.
Board Member
Immatics Biotechnologies
Germany
Biography
Prof Dr Erich Schlick has over 25 years of experience in the healthcare sector. Erich Schlick spent five years at the US National Cancer Institute, and over 15 years with BASF Pharma, including ten years as the executive board member responsible for worldwide R&D. He established BASF Pharma’s immunology business, and its U.S. biotech centre specializing in immunology and monoclonal antibodies. From 2001 to September 2005, Erich Schlick worked for 3i, in his last position as head of 3i’s Healthcare Team in Germany and as Deputy Head of 3i Healthcare Worldwide. In September 2005, he joined Wellington Partners as a General Partner of their Life Science Fund.
Research Interest
Management
